Compile Data Set for Download or QSAR

Found 109 hits with Last Name = 'gebauer' and Initial = 'd'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cathepsin S (Homo sapiens (Human))	BDBM50299206 ((S)-1-(3-(4-chloro-3-((4-chlorophenyl)ethynyl)phen...) Show SMILES CN1CCC(CC1)C1CCN(C[C@H](O)Cn2nc(c3CN(CCc23)S(C)(=O)=O)-c2ccc(Cl)c(c2)C#Cc2ccc(Cl)cc2)CC1 |r| Show InChI InChI=1S/C35H43Cl2N5O3S/c1-39-16-11-26(12-17-39)27-13-18-40(19-14-27)22-31(43)23-42-34-15-20-41(46(2,44)45)24-32(34)35(38-42)29-7-10-33(37)28(21-29)6-3-25-4-8-30(36)9-5-25/h4-5,7-10,21,26-27,31,43H,11-20,22-24H2,1-2H3/t31-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299205 ((S)-1-(4,4'-bipiperidin-1-yl)-3-(3-(4-chloro-3-((4...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2C[C@@H](O)CN1CCC(CC1)C1CCNCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 |r| Show InChI InChI=1S/C34H41Cl2N5O3S/c1-45(43,44)40-19-14-33-31(23-40)34(28-6-9-32(36)27(20-28)5-2-24-3-7-29(35)8-4-24)38-41(33)22-30(42)21-39-17-12-26(13-18-39)25-10-15-37-16-11-25/h3-4,6-9,20,25-26,30,37,42H,10-19,21-23H2,1H3/t30-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299203 ((S)-tert-butyl 1'-(3-(3-(4-chloro-3-((4-chlorophen...) Show SMILES CC(C)(C)OC(=O)N1CCC(CC1)C1CCN(C[C@H](O)Cn2nc(c3CN(CCc23)S(C)(=O)=O)-c2ccc(Cl)c(c2)C#Cc2ccc(Cl)cc2)CC1 |r| Show InChI InChI=1S/C39H49Cl2N5O5S/c1-39(2,3)51-38(48)44-20-15-29(16-21-44)28-13-18-43(19-14-28)24-33(47)25-46-36-17-22-45(52(4,49)50)26-34(36)37(42-46)31-9-12-35(41)30(23-31)8-5-27-6-10-32(40)11-7-27/h6-7,9-12,23,28-29,33,47H,13-22,24-26H2,1-4H3/t33-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299186 (CHEMBL573418 | methyl 1-(3-(3-(4-chloro-3-((4-chlo...) Show SMILES COC(=O)C1CCN(CC(O)Cn2nc(c3CN(CCc23)S(C)(=O)=O)-c2ccc(Cl)c(c2)C#Cc2ccc(Cl)cc2)CC1 Show InChI InChI=1S/C31H34Cl2N4O5S/c1-42-31(39)22-11-14-35(15-12-22)18-26(38)19-37-29-13-16-36(43(2,40)41)20-27(29)30(34-37)24-7-10-28(33)23(17-24)6-3-21-4-8-25(32)9-5-21/h4-5,7-10,17,22,26,38H,11-16,18-20H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299204 ((S)-1-(1'-(3-(3-(4-chloro-3-((4-chlorophenyl)ethyn...) Show SMILES CC(=O)N1CCC(CC1)C1CCN(C[C@H](O)Cn2nc(c3CN(CCc23)S(C)(=O)=O)-c2ccc(Cl)c(c2)C#Cc2ccc(Cl)cc2)CC1 |r| Show InChI InChI=1S/C36H43Cl2N5O4S/c1-25(44)41-18-13-28(14-19-41)27-11-16-40(17-12-27)22-32(45)23-43-35-15-20-42(48(2,46)47)24-33(35)36(39-43)30-7-10-34(38)29(21-30)6-3-26-4-8-31(37)9-5-26/h4-5,7-10,21,27-28,32,45H,11-20,22-24H2,1-2H3/t32-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314176 (4-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(piperidin-1-y...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C37H47F3N6O4S2/c1-52(48,49)44-21-14-31-29(25-44)36(27-10-11-30(37(38,39)40)34(24-27)51-23-22-42-15-5-2-6-16-42)41-45(31)18-7-17-43-19-12-28(13-20-43)46-32-8-3-4-9-33(32)50-26-35(46)47/h3-4,8-11,24,28H,2,5-7,12-23,25-26H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	30	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314168 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(piperidin-1-y...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C33H47F3N6O3S2/c1-47(44,45)40-20-12-29-27(24-40)32(37-42(29)17-6-15-39-18-10-26(11-19-39)41-16-5-7-31(41)43)25-8-9-28(33(34,35)36)30(23-25)46-22-21-38-13-3-2-4-14-38/h8-9,23,26H,2-7,10-22,24H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50321626 (CHEMBL1171504 | N-(2-chloro-5-(1-(3-(4-(6-chloro-3...) Show SMILES Cn1c2ccc(Cl)cc2n(C2CCN(CCCn3cncc(-c4ccc(Cl)c(CNC(=O)c5ccc(F)cc5)c4)c3=O)CC2)c1=O Show InChI InChI=1S/C34H33Cl2FN6O3/c1-40-30-10-6-25(35)18-31(30)43(34(40)46)27-11-15-41(16-12-27)13-2-14-42-21-38-20-28(33(42)45)23-5-9-29(36)24(17-23)19-39-32(44)22-3-7-26(37)8-4-22/h3-10,17-18,20-21,27H,2,11-16,19H2,1H3,(H,39,44)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL MMDB PC cid PC sid PDB UniChem Similars	MMDB PDB Article PubMed	n/a	n/a	40	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 4060-4 (2010) Article DOI: 10.1016/j.bmcl.2010.05.086 BindingDB Entry DOI: 10.7270/Q20Z747Q
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cathepsin S (Homo sapiens (Human))	BDBM50314171 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(octahydroisoq...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCC3CCCCC3C2)c1)C(F)(F)F Show InChI InChI=1S/C37H53F3N6O3S2/c1-51(48,49)44-21-14-33-31(26-44)36(41-46(33)17-5-15-42-19-12-30(13-20-42)45-16-4-8-35(45)47)28-9-10-32(37(38,39)40)34(24-28)50-23-22-43-18-11-27-6-2-3-7-29(27)25-43/h9-10,24,27,29-30H,2-8,11-23,25-26H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	55	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50321625 (CHEMBL1171503 | CatS_4 | N-(2-chloro-5-(2-(3-(4-(6...) Show SMILES Cn1c2ccc(Cl)cc2n(C2CCN(CCCn3nccc(-c4ccc(Cl)c(CNC(=O)c5ccc(F)cc5)c4)c3=O)CC2)c1=O Show InChI InChI=1S/C34H33Cl2FN6O3/c1-40-30-10-6-25(35)20-31(30)43(34(40)46)27-12-17-41(18-13-27)15-2-16-42-33(45)28(11-14-39-42)23-5-9-29(36)24(19-23)21-38-32(44)22-3-7-26(37)8-4-22/h3-11,14,19-20,27H,2,12-13,15-18,21H2,1H3,(H,38,44)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid PDB UniChem Similars	PDB Article PubMed	n/a	n/a	60	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 4060-4 (2010) Article DOI: 10.1016/j.bmcl.2010.05.086 BindingDB Entry DOI: 10.7270/Q20Z747Q
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cathepsin S (Homo sapiens (Human))	BDBM50314164 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(pyrrolidin-1-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCCC2)c1)C(F)(F)F Show InChI InChI=1S/C32H45F3N6O3S2/c1-46(43,44)39-19-11-28-26(23-39)31(24-7-8-27(32(33,34)35)29(22-24)45-21-20-37-12-2-3-13-37)36-41(28)16-5-14-38-17-9-25(10-18-38)40-15-4-6-30(40)42/h7-8,22,25H,2-6,9-21,23H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299198 (CHEMBL573474 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CNCc2ccc(Cl)c(Cl)c2)cc1 Show InChI InChI=1S/C36H38Cl3N5O3S/c1-48(45,46)43-16-13-35-31(25-43)36(41-44(35)15-2-14-42-17-19-47-20-18-42)30-10-12-32(37)29(22-30)9-7-26-3-5-27(6-4-26)23-40-24-28-8-11-33(38)34(39)21-28/h3-6,8,10-12,21-22,40H,2,13-20,23-25H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299185 (1-(3-(4-chloro-3-((4-chlorophenyl)ethynyl)phenyl)-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCCCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 Show InChI InChI=1S/C29H32Cl2N4O3S/c1-39(37,38)34-16-13-28-26(20-34)29(32-35(28)19-25(36)18-33-14-3-2-4-15-33)23-9-12-27(31)22(17-23)8-5-21-6-10-24(30)11-7-21/h6-7,9-12,17,25,36H,2-4,13-16,18-20H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	80	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299201 ((R)-methyl 2-(4-((2-chloro-5-(5-(methylsulfonyl)-1...) Show SMILES COC(=O)[C@H](NCc1ccc(cc1)C#Cc1cc(ccc1Cl)-c1nn(CCCN2CCOCC2)c2CCN(Cc12)S(C)(=O)=O)c1ccccc1 |r| Show InChI InChI=1S/C38H42ClN5O5S/c1-48-38(45)37(30-7-4-3-5-8-30)40-26-29-11-9-28(10-12-29)13-14-31-25-32(15-16-34(31)39)36-33-27-43(50(2,46)47)20-17-35(33)44(41-36)19-6-18-42-21-23-49-24-22-42/h3-5,7-12,15-16,25,37,40H,6,17-24,26-27H2,1-2H3/t37-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299200 ((R)-2-(4-((2-chloro-5-(5-(methylsulfonyl)-1-(3-mor...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CN[C@@H](CO)c2ccccc2)cc1 |r| Show InChI InChI=1S/C37H42ClN5O4S/c1-48(45,46)42-19-16-36-33(26-42)37(40-43(36)18-5-17-41-20-22-47-23-21-41)32-14-15-34(38)31(24-32)13-12-28-8-10-29(11-9-28)25-39-35(27-44)30-6-3-2-4-7-30/h2-4,6-11,14-15,24,35,39,44H,5,16-23,25-27H2,1H3/t35-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	100	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50321627 (CHEMBL1171505 | CatS_6 | N-(2-chloro-5-(4-(3-(4-(6...) Show SMILES Cn1c2ccc(Cl)cc2n(C2CCN(CCCn3ccnc(-c4ccc(Cl)c(CNC(=O)c5ccc(F)cc5)c4)c3=O)CC2)c1=O Show InChI InChI=1S/C34H33Cl2FN6O3/c1-40-29-10-6-25(35)20-30(29)43(34(40)46)27-11-16-41(17-12-27)14-2-15-42-18-13-38-31(33(42)45)23-5-9-28(36)24(19-23)21-39-32(44)22-3-7-26(37)8-4-22/h3-10,13,18-20,27H,2,11-12,14-17,21H2,1H3,(H,39,44)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid PDB UniChem Similars	PDB Article PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 4060-4 (2010) Article DOI: 10.1016/j.bmcl.2010.05.086 BindingDB Entry DOI: 10.7270/Q20Z747Q
					More data for this Ligand-Target Pair				3D Structure (crystal)
Cathepsin S (Homo sapiens (Human))	BDBM50299187 (1-(3-(3-(4-chloro-3-((4-chlorophenyl)ethynyl)pheny...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)C(N)=O)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 Show InChI InChI=1S/C30H33Cl2N5O4S/c1-42(40,41)36-15-12-28-26(19-36)29(34-37(28)18-25(38)17-35-13-10-21(11-14-35)30(33)39)23-6-9-27(32)22(16-23)5-2-20-3-7-24(31)8-4-20/h3-4,6-9,16,21,25,38H,10-15,17-19H2,1H3,(H2,33,39)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314170 (1-(1-(3-(3-(3-(2-(4-methylpiperidin-1-yl)ethylthio...) Show SMILES CC1CCN(CCSc2cc(ccc2C(F)(F)F)-c2nn(CCCN3CCC(CC3)N3CCCC3=O)c3CCN(Cc23)S(C)(=O)=O)CC1 Show InChI InChI=1S/C34H49F3N6O3S2/c1-25-8-16-40(17-9-25)21-22-47-31-23-26(6-7-29(31)34(35,36)37)33-28-24-41(48(2,45)46)20-12-30(28)43(38-33)15-4-13-39-18-10-27(11-19-39)42-14-3-5-32(42)44/h6-7,23,25,27H,3-5,8-22,24H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	110	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299202 ((S)-methyl 2-(4-((2-chloro-5-(5-(methylsulfonyl)-1...) Show SMILES COC(=O)[C@@H](NCc1ccc(cc1)C#Cc1cc(ccc1Cl)-c1nn(CCCN2CCOCC2)c2CCN(Cc12)S(C)(=O)=O)c1ccccc1 |r| Show InChI InChI=1S/C38H42ClN5O5S/c1-48-38(45)37(30-7-4-3-5-8-30)40-26-29-11-9-28(10-12-29)13-14-31-25-32(15-16-34(31)39)36-33-27-43(50(2,46)47)20-17-35(33)44(41-36)19-6-18-42-21-23-49-24-22-42/h3-5,7-12,15-16,25,37,40H,6,17-24,26-27H2,1-2H3/t37-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	120	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314181 (CHEMBL1089278 | N-(2-(5-(1-(2-hydroxy-3-(4-(2-oxop...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCNC(=O)Cc2ccccc2)c1)C(F)(F)F Show InChI InChI=1S/C36H45F3N6O5S2/c1-52(49,50)43-18-13-31-29(24-43)35(41-45(31)23-28(46)22-42-16-11-27(12-17-42)44-15-5-8-34(44)48)26-9-10-30(36(37,38)39)32(21-26)51-19-14-40-33(47)20-25-6-3-2-4-7-25/h2-4,6-7,9-10,21,27-28,46H,5,8,11-20,22-24H2,1H3,(H,40,47)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	130	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314161 (1-(1-(3-(3-(3-(2-(4-methylpiperazin-1-yl)ethylthio...) Show SMILES CN1CCN(CCSc2cc(ccc2C(F)(F)F)-c2nn(CCCN3CCC(CC3)N3CCCC3=O)c3CCN(Cc23)S(C)(=O)=O)CC1 Show InChI InChI=1S/C33H48F3N7O3S2/c1-38-17-19-40(20-18-38)21-22-47-30-23-25(6-7-28(30)33(34,35)36)32-27-24-41(48(2,45)46)16-10-29(27)43(37-32)13-4-11-39-14-8-26(9-15-39)42-12-3-5-31(42)44/h6-7,23,26H,3-5,8-22,24H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	130	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299182 (1-(3-(4-chloro-3-((4-chlorophenyl)ethynyl)phenyl)-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 Show InChI InChI=1S/C28H30Cl2N4O4S/c1-39(36,37)33-11-10-27-25(19-33)28(31-34(27)18-24(35)17-32-12-14-38-15-13-32)22-6-9-26(30)21(16-22)5-2-20-3-7-23(29)8-4-20/h3-4,6-9,16,24,35H,10-15,17-19H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299197 (CHEMBL573636 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CNCc2ccc(Cl)cc2)cc1 Show InChI InChI=1S/C36H39Cl2N5O3S/c1-47(44,45)42-18-15-35-33(26-42)36(40-43(35)17-2-16-41-19-21-46-22-20-41)31-11-14-34(38)30(23-31)10-7-27-3-5-28(6-4-27)24-39-25-29-8-12-32(37)13-9-29/h3-6,8-9,11-14,23,39H,2,15-22,24-26H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	140	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299183 (CHEMBL573197 | tert-butyl 4-(3-(3-(4-chloro-3-((4-...) Show SMILES CC(C)(C)OC(=O)N1CCN(CC(O)Cn2nc(c3CN(CCc23)S(C)(=O)=O)-c2ccc(Cl)c(c2)C#Cc2ccc(Cl)cc2)CC1 Show InChI InChI=1S/C33H39Cl2N5O5S/c1-33(2,3)45-32(42)38-17-15-37(16-18-38)20-27(41)21-40-30-13-14-39(46(4,43)44)22-28(30)31(36-40)25-9-12-29(35)24(19-25)8-5-23-6-10-26(34)11-7-23/h6-7,9-12,19,27,41H,13-18,20-22H2,1-4H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	150	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314169 (1-(1-(3-(3-(3-(2-(4-tert-butylpiperidin-1-yl)ethyl...) Show SMILES CC(C)(C)C1CCN(CCSc2cc(ccc2C(F)(F)F)-c2nn(CCCN3CCC(CC3)N3CCCC3=O)c3CCN(Cc23)S(C)(=O)=O)CC1 Show InChI InChI=1S/C37H55F3N6O3S2/c1-36(2,3)28-10-18-43(19-11-28)23-24-50-33-25-27(8-9-31(33)37(38,39)40)35-30-26-44(51(4,48)49)22-14-32(30)46(41-35)17-6-15-42-20-12-29(13-21-42)45-16-5-7-34(45)47/h8-9,25,28-29H,5-7,10-24,26H2,1-4H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	160	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299189 (CHEMBL573421 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CNS(=O)(=O)c2ccccc2)cc1 Show InChI InChI=1S/C35H38ClN5O5S2/c1-47(42,43)40-19-16-34-32(26-40)35(38-41(34)18-5-17-39-20-22-46-23-21-39)30-14-15-33(36)29(24-30)13-12-27-8-10-28(11-9-27)25-37-48(44,45)31-6-3-2-4-7-31/h2-4,6-11,14-15,24,37H,5,16-23,25-26H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	160	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314168 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(piperidin-1-y...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C33H47F3N6O3S2/c1-47(44,45)40-20-12-29-27(24-40)32(37-42(29)17-6-15-39-18-10-26(11-19-39)41-16-5-7-31(41)43)25-8-9-28(33(34,35)36)30(23-25)46-22-21-38-13-3-2-4-14-38/h8-9,23,26H,2-7,10-22,24H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	170	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299199 ((+/-)-N-(4-((2-chloro-5-(5-(methylsulfonyl)-1-(3-m...) Show SMILES CC(NCc1ccc(cc1)C#Cc1cc(ccc1Cl)-c1nn(CCCN2CCOCC2)c2CCN(Cc12)S(C)(=O)=O)c1ccccc1 Show InChI InChI=1S/C37H42ClN5O3S/c1-28(31-7-4-3-5-8-31)39-26-30-11-9-29(10-12-30)13-14-32-25-33(15-16-35(32)38)37-34-27-42(47(2,44)45)20-17-36(34)43(40-37)19-6-18-41-21-23-46-24-22-41/h3-5,7-12,15-16,25,28,39H,6,17-24,26-27H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	190	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314167 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(4-phenylpiper...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCC(CC2)c2ccccc2)c1)C(F)(F)F Show InChI InChI=1S/C39H51F3N6O3S2/c1-53(50,51)46-24-16-35-33(28-46)38(43-48(35)19-6-17-44-22-14-32(15-23-44)47-18-5-9-37(47)49)31-10-11-34(39(40,41)42)36(27-31)52-26-25-45-20-12-30(13-21-45)29-7-3-2-4-8-29/h2-4,7-8,10-11,27,30,32H,5-6,9,12-26,28H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314157 (1-(1-(3-(3-(3-(2-hydroxyethylthio)-4-(trifluoromet...) Show SMILES CS(=O)(=O)C1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCO)c1)C(F)(F)F Show InChI InChI=1S/C29H39F3N4O4S2/c1-42(39,40)22-6-8-25-23(19-22)28(20-5-7-24(29(30,31)32)26(18-20)41-17-16-37)33-36(25)13-3-11-34-14-9-21(10-15-34)35-12-2-4-27(35)38/h5,7,18,21-22,37H,2-4,6,8-17,19H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299205 ((S)-1-(4,4'-bipiperidin-1-yl)-3-(3-(4-chloro-3-((4...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2C[C@@H](O)CN1CCC(CC1)C1CCNCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 |r| Show InChI InChI=1S/C34H41Cl2N5O3S/c1-45(43,44)40-19-14-33-31(23-40)34(28-6-9-32(36)27(20-28)5-2-24-3-7-29(35)8-4-24)38-41(33)22-30(42)21-39-17-12-26(13-18-39)25-10-15-37-16-11-25/h3-4,6-9,20,25-26,30,37,42H,10-19,21-23H2,1H3/t30-/m0/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	200	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as invariant chain li degradation by western blotting				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314176 (4-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(piperidin-1-y...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1C(=O)COc2ccccc12)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C37H47F3N6O4S2/c1-52(48,49)44-21-14-31-29(25-44)36(27-10-11-30(37(38,39)40)34(24-27)51-23-22-42-15-5-2-6-16-42)41-45(31)18-7-17-43-19-12-28(13-20-43)46-32-8-3-4-9-33(32)50-26-35(46)47/h3-4,8-11,24,28H,2,5-7,12-23,25-26H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	210	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314156 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-phenoxyethylth...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCOc2ccccc2)c1)C(F)(F)F Show InChI InChI=1S/C34H42F3N5O4S2/c1-48(44,45)40-20-14-30-28(24-40)33(38-42(30)17-6-15-39-18-12-26(13-19-39)41-16-5-9-32(41)43)25-10-11-29(34(35,36)37)31(23-25)47-22-21-46-27-7-3-2-4-8-27/h2-4,7-8,10-11,23,26H,5-6,9,12-22,24H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	220	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299196 (CHEMBL573657 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES COc1ccc(CNCc2ccc(cc2)C#Cc2cc(ccc2Cl)-c2nn(CCCN3CCOCC3)c3CCN(Cc23)S(C)(=O)=O)cc1 Show InChI InChI=1S/C37H42ClN5O4S/c1-46-33-13-9-30(10-14-33)26-39-25-29-6-4-28(5-7-29)8-11-31-24-32(12-15-35(31)38)37-34-27-42(48(2,44)45)19-16-36(34)43(40-37)18-3-17-41-20-22-47-23-21-41/h4-7,9-10,12-15,24,39H,3,16-23,25-27H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	230	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314166 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-morpholinoethy...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCOCC2)c1)C(F)(F)F Show InChI InChI=1S/C32H45F3N6O4S2/c1-47(43,44)39-15-9-28-26(23-39)31(36-41(28)12-3-10-37-13-7-25(8-14-37)40-11-2-4-30(40)42)24-5-6-27(32(33,34)35)29(22-24)46-21-18-38-16-19-45-20-17-38/h5-6,22,25H,2-4,7-21,23H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	270	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50321624 (CHEMBL1171502 | N-(2-chloro-5-(1-(3-(4-(6-chloro-3...) Show SMILES Cn1c2ccc(Cl)cc2n(C2CCN(CCCn3nc(ccc3=O)-c3ccc(Cl)c(CNC(=O)c4ccc(F)cc4)c3)CC2)c1=O Show InChI InChI=1S/C34H33Cl2FN6O3/c1-40-30-11-6-25(35)20-31(30)43(34(40)46)27-13-17-41(18-14-27)15-2-16-42-32(44)12-10-29(39-42)23-5-9-28(36)24(19-23)21-38-33(45)22-3-7-26(37)8-4-22/h3-12,19-20,27H,2,13-18,21H2,1H3,(H,38,45)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	320	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 4060-4 (2010) Article DOI: 10.1016/j.bmcl.2010.05.086 BindingDB Entry DOI: 10.7270/Q20Z747Q
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314173 (5-(methylsulfonyl)-3-(3-(2-(piperidin-1-yl)ethylth...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C33H49F3N6O2S2/c1-46(43,44)41-21-12-30-28(25-41)32(37-42(30)18-7-15-39-19-10-27(11-20-39)40-16-5-6-17-40)26-8-9-29(33(34,35)36)31(24-26)45-23-22-38-13-3-2-4-14-38/h8-9,24,27H,2-7,10-23,25H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	320	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314169 (1-(1-(3-(3-(3-(2-(4-tert-butylpiperidin-1-yl)ethyl...) Show SMILES CC(C)(C)C1CCN(CCSc2cc(ccc2C(F)(F)F)-c2nn(CCCN3CCC(CC3)N3CCCC3=O)c3CCN(Cc23)S(C)(=O)=O)CC1 Show InChI InChI=1S/C37H55F3N6O3S2/c1-36(2,3)28-10-18-43(19-11-28)23-24-50-33-25-27(8-9-31(33)37(38,39)40)35-30-26-44(51(4,48)49)22-14-32(30)46(41-35)17-6-15-42-20-12-29(13-21-42)45-16-5-7-34(45)47/h8-9,25,28-29H,5-7,10-24,26H2,1-4H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	330	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314165 (1-(1-(3-(3-(3-(2-(4-hydroxypiperidin-1-yl)ethylthi...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCC(O)CC2)c1)C(F)(F)F Show InChI InChI=1S/C33H47F3N6O4S2/c1-48(45,46)40-19-11-29-27(23-40)32(37-42(29)14-3-12-38-15-7-25(8-16-38)41-13-2-4-31(41)44)24-5-6-28(33(34,35)36)30(22-24)47-21-20-39-17-9-26(43)10-18-39/h5-6,22,25-26,43H,2-4,7-21,23H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	340	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299195 (CHEMBL573632 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES Cc1ccc(CNCc2ccc(cc2)C#Cc2cc(ccc2Cl)-c2nn(CCCN3CCOCC3)c3CCN(Cc23)S(C)(=O)=O)cc1 Show InChI InChI=1S/C37H42ClN5O3S/c1-28-4-6-30(7-5-28)25-39-26-31-10-8-29(9-11-31)12-13-32-24-33(14-15-35(32)38)37-34-27-42(47(2,44)45)19-16-36(34)43(40-37)18-3-17-41-20-22-46-23-21-41/h4-11,14-15,24,39H,3,16-23,25-27H2,1-2H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	350	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314165 (1-(1-(3-(3-(3-(2-(4-hydroxypiperidin-1-yl)ethylthi...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCC(O)CC2)c1)C(F)(F)F Show InChI InChI=1S/C33H47F3N6O4S2/c1-48(45,46)40-19-11-29-27(23-40)32(37-42(29)14-3-12-38-15-7-25(8-16-38)41-13-2-4-31(41)44)24-5-6-28(33(34,35)36)30(22-24)47-21-20-39-17-9-26(43)10-18-39/h5-6,22,25-26,43H,2-4,7-21,23H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	350	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299190 (CHEMBL573422 | N-(4-((2-chloro-5-(5-(methylsulfony...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CNC(=O)c2ccccc2)cc1 Show InChI InChI=1S/C36H38ClN5O4S/c1-47(44,45)41-19-16-34-32(26-41)35(39-42(34)18-5-17-40-20-22-46-23-21-40)31-14-15-33(37)30(24-31)13-12-27-8-10-28(11-9-27)25-38-36(43)29-6-3-2-4-7-29/h2-4,6-11,14-15,24H,5,16-23,25-26H2,1H3,(H,38,43)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	350	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314179 (CHEMBL1089277 | rac-4-fluoro-N-(2-(5-(1-(2-hydroxy...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCNC(=O)c2ccc(F)cc2)c1)C(F)(F)F Show InChI InChI=1S/C35H42F4N6O5S2/c1-52(49,50)43-17-12-30-28(22-43)33(41-45(30)21-27(46)20-42-15-10-26(11-16-42)44-14-2-3-32(44)47)24-6-9-29(35(37,38)39)31(19-24)51-18-13-40-34(48)23-4-7-25(36)8-5-23/h4-9,19,26-27,46H,2-3,10-18,20-22H2,1H3,(H,40,48)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	360	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314175 (5-(methylsulfonyl)-3-(3-(2-(piperidin-1-yl)ethylth...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCCCC1)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C29H42F3N5O2S2/c1-41(38,39)36-18-11-26-24(22-36)28(33-37(26)17-8-16-34-12-4-2-5-13-34)23-9-10-25(29(30,31)32)27(21-23)40-20-19-35-14-6-3-7-15-35/h9-10,21H,2-8,11-20,22H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of cathepsin S in human JY cells assessed as inhibition of invariant chain degradation				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314177 (CHEMBL1089275 | rac-N-(2-(5-(1-(2-hydroxy-3-(4-(2-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCNC(=O)c2ccccc2)c1)C(F)(F)F Show InChI InChI=1S/C35H43F3N6O5S2/c1-51(48,49)42-18-13-30-28(23-42)33(40-44(30)22-27(45)21-41-16-11-26(12-17-41)43-15-5-8-32(43)46)25-9-10-29(35(36,37)38)31(20-25)50-19-14-39-34(47)24-6-3-2-4-7-24/h2-4,6-7,9-10,20,26-27,45H,5,8,11-19,21-23H2,1H3,(H,39,47)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314175 (5-(methylsulfonyl)-3-(3-(2-(piperidin-1-yl)ethylth...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCCCC1)-c1ccc(c(SCCN2CCCCC2)c1)C(F)(F)F Show InChI InChI=1S/C29H42F3N5O2S2/c1-41(38,39)36-18-11-26-24(22-36)28(33-37(26)17-8-16-34-12-4-2-5-13-34)23-9-10-25(29(30,31)32)27(21-23)40-20-19-35-14-6-3-7-15-35/h9-10,21H,2-8,11-20,22H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299184 (1-(3-(4-chloro-3-((4-chlorophenyl)ethynyl)phenyl)-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCNCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(Cl)cc1 Show InChI InChI=1S/C28H31Cl2N5O3S/c1-39(37,38)34-13-10-27-25(19-34)28(32-35(27)18-24(36)17-33-14-11-31-12-15-33)22-6-9-26(30)21(16-22)5-2-20-3-7-23(29)8-4-20/h3-4,6-9,16,24,31,36H,10-15,17-19H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	380	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314178 (CHEMBL1089276 | rac-4-hydroxy-N-(2-(5-(1-(2-hydrox...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CC(O)CN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCNC(=O)c2ccc(O)cc2)c1)C(F)(F)F Show InChI InChI=1S/C35H43F3N6O6S2/c1-52(49,50)42-17-12-30-28(22-42)33(40-44(30)21-27(46)20-41-15-10-25(11-16-41)43-14-2-3-32(43)47)24-6-9-29(35(36,37)38)31(19-24)51-18-13-39-34(48)23-4-7-26(45)8-5-23/h4-9,19,25,27,45-46H,2-3,10-18,20-22H2,1H3,(H,39,48)	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	390	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50314164 (1-(1-(3-(5-(methylsulfonyl)-3-(3-(2-(pyrrolidin-1-...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCC(CC1)N1CCCC1=O)-c1ccc(c(SCCN2CCCC2)c1)C(F)(F)F Show InChI InChI=1S/C32H45F3N6O3S2/c1-46(43,44)39-19-11-28-26(23-39)31(24-7-8-27(32(33,34)35)29(22-24)45-21-20-37-12-2-3-13-37)36-41(28)16-5-14-38-17-9-25(10-18-38)40-15-4-6-30(40)42/h7-8,22,25H,2-6,9-21,23H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	410	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research& Development Curated by ChEMBL					Assay Description Inhibition of human cathepsin S				Bioorg Med Chem Lett 20: 2370-4 (2010) Article DOI: 10.1016/j.bmcl.2010.01.108 BindingDB Entry DOI: 10.7270/Q2G160Z4
					More data for this Ligand-Target Pair
Cathepsin S (Homo sapiens (Human))	BDBM50299192 (CHEMBL573655 | N-benzyl-1-(4-((2-chloro-5-(5-(meth...) Show SMILES CS(=O)(=O)N1CCc2c(C1)c(nn2CCCN1CCOCC1)-c1ccc(Cl)c(c1)C#Cc1ccc(CNCc2ccccc2)cc1 Show InChI InChI=1S/C36H40ClN5O3S/c1-46(43,44)41-19-16-35-33(27-41)36(39-42(35)18-5-17-40-20-22-45-23-21-40)32-14-15-34(37)31(24-32)13-12-28-8-10-30(11-9-28)26-38-25-29-6-3-2-4-7-29/h2-4,6-11,14-15,24,38H,5,16-23,25-27H2,1H3	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	420	n/a	n/a	n/a	n/a	n/a	n/a
Johnson& Johnson Pharmaceutical Research and Development Curated by ChEMBL					Assay Description Inhibition of human recombinant cathepsin S expressed in baculovirus by FRET assay				Bioorg Med Chem Lett 19: 6135-9 (2009) Article DOI: 10.1016/j.bmcl.2009.09.013 BindingDB Entry DOI: 10.7270/Q2R49QTP
					More data for this Ligand-Target Pair

Displayed 1 to 50 (of 109 total )  |  Next  |  Last  >>

Jump to: